Mitomycin C after ureteroscopy for upper urinary tract cancer
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether giving a chemotherapy drug called mitomycin C directly into the bladder after a ureteroscopy can help prevent upper tract urothelial cancer from coming back or spreading. It is for people who are newly suspected of having this cancer and are about to have a diagnostic ureteroscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected cancer in the upper urinary tract (the kidneys or the tubes that carry urine to the bladder).
- You need a procedure called a ureteroscopy, where a thin tube with a camera is used to look inside your urinary tract.
- You have not had bladder cancer in the past or currently.
- You have never been diagnosed with this type of cancer before.
- You have not had a ureteroscopy in the last 6 months.
- You do not have an untreated urinary tract infection, a perforation (tear) in your urinary tract, or low blood cell counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This program provides access to a chemotherapy drug called mitomycin, given as a liquid into the kidney area, for people with a certain type of cancer in the upper urinary tract. It aims to see if this treatment can help when standard options are not suitable.
This Phase 3 trial studies whether using gemcitabine (a chemotherapy medicine) in the urinary tract better prevents cancer from coming back than using a simple water wash. It involves people with upper tract urothelial carcinoma who are having curative surgery to remove the affected ureter or kidney tube.
This study is testing whether giving a single dose of chemotherapy directly into the kidney and ureter right after a scope procedure helps prevent upper urinary tract tumors from coming back. It’s for people who are about to have a scope to diagnose or treat a suspected or known tumor in the upper urinary tract.
This trial tests whether giving mitomycin directly into the bladder before surgery can help people with high-risk non-muscle-invasive bladder cancer. The goal is to see if this approach is safe and effective at preventing cancer from coming back.
This study tests a combination of two chemotherapy drugs, mitomycin-C and gemcitabine, given directly into the bladder for people with high-risk bladder cancer that hasn't been controlled with BCG therapy. It's an option for those who can't or don't want to have their bladder removed.
This trial tests a combination of two chemotherapy drugs, gemcitabine and mitomycin, given directly into the kidney or ureter through a thin tube. It is for people with a high-risk but non-invasive form of upper urinary tract cancer that has not spread into deeper tissues.
Hear when a new Urothelial Carcinoma Ureter trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.